Navigation Links
Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles
Date:6/20/2008

CHAPEL HILL, N.C., June 20 /PRNewswire/ -- A recent study by Best Practices, LLC found that assessment of readiness for launch by a non-New Product Introduction team was one of the most important factors in successful launches. This study, Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles, can provide executives with the knowledge and data to optimize their launch governance groups and maximize the success of product launches.

You can download a complimentary excerpt of our study, "Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles" by clicking or pasting the following link in your browser: http://www3.best-in-class.com/rr964.htm .

Some key findings from this study include:

-- A much higher percentage (55%) of companies with very effective launches involve Sales in a consulted role throughout the launch process compared to the benchmark class as a whole (30%).

-- 73% of very effective organizations have representation from Business Managers on their launch groups compared to just 40% of the total benchmark class, and overall, very effective organizations have broader representation across the organization.

-- The use of self-assessment by New Product Introduction teams and assessment by non-New Product Introduction teams is extremely prevalent by very effective organizations, and is key to addressing all issues necessary to have problem-free launches.

For more information on Best Practices Research & Consulting services or reports, please contact Grant Houston at (919) 767-9182 or ghouston@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies o
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Clues to ensuring anti-HIV drugs are taken in Africa
2. Best Practice Database: Complimentary Excerpt of Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles
3. Uncover Best Measures for Ensuring Brand Safety in the Pharma Industry
4. Eligard(R) six-month formulation successfully completes European approval procedure
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
7. Bacteria successful in cancer treatment
8. Congress Poised to Add Millions of Uninsured Children to Successful, Bipartisan Health Plan
9. Cell growth technology promises more successful drug development
10. Wacoal Renews Successful Support the Girls Program
11. A New Interactive Consumer Experience Highlighting Successful Weight Loss Strategies is Coming to a Mall Near You
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 Cloud Medical Doctor Software Corporation ... Medical Practice Business Operations solutions and Billing Services for ... Security solutions for all industries announced today that its ... floor of the CME in Chicago by PRICE Futures ... we are very proud of the recognition that our ...
(Date:9/2/2014)... 2014 On August 30, 2014, Harper’s ... “Why You Should Wash Your Face .” According ... global population breathes air considered polluted by the World ... in the skin’s pores destroying its natural oils. These ... radicals that may cause cell damage, redness, aging ...
(Date:9/2/2014)... diagnosed with early-stage breast cancer in California, the percentage ... 2011, although this procedure was not associated with a ... according to a study in the September 3 issue ... surgery for the removal of one breast was associated ... options examined in the study. , Randomized trials have ...
(Date:9/2/2014)... within a few days of discharge do so principally because ... in other parts of the health care system, according to ... Annals of Emergency Medicine ( "Return Visits to the ... asked why they did not follow up as an outpatient, ... wait until their scheduled appointment or being instructed to return ...
(Date:9/2/2014)... Australia (PRWEB) September 03, 2014 Operators ... attend to millions of people annually, arranging care and ... not-for-profit and private enterprises are expected to derive $39.4 ... funding, donations and private income. Over the five years ... an annualised rate of 6.6%, including growth of 4.1% ...
Breaking Medicine News(10 mins):Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Increase seen in use of double mastectomy 2Health News:Increase seen in use of double mastectomy 3Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Community Services in Australia Industry Market Research Report Now Updated by IBISWorld 3
... for ependymoma, a rare tumor with few treatment ... the effort, which used a new, faster drug ... technology with the first accurate animal model of ... and existing drugs as possible ependymoma treatment candidates. ...
... , THURSDAY, Sept. 15 (HealthDay News) -- Experts ... lead the battle against alcohol abuse. A group ... avoid the harmful effects of excess alcohol, and it also ... has become the third leading risk factor in preventable and ...
... how white blood cells kill diseased tissue using deadly granules, ... The researchers, from Imperial College London and the University of ... see the inner workings of white blood cells at the ... cell rearranges its scaffolding of actin proteins on the inside ...
... Researchers at Cleveland Clinic have received a grant from the ... of a blood test that conclusively identifies concussions in college ... taken before and after a game searches for a ... in elevated levels in an athlete,s blood. Damir Janigro, ...
... For patients with ovarian cancer and their physicians, resistance ... Moffitt Cancer Center have identified a molecular pathway that ... chemotherapy resistance. They are hopeful that the discovery may ... with ovarian cancer; reversing resistance to chemotherapy and improving ...
... Sept. 15 (HealthDay News) -- Not enough children and teens ... for Disease Control and Prevention reveals. Drinking milk is ... although young people need the calcium, vitamin D and other ... consume low-fat milk and milk products to avoid unnecessary fat ...
Cached Medicine News:Health News:New strategy likely to speed drug development for rare cancers 2Health News:New strategy likely to speed drug development for rare cancers 3Health News:Doctors Urged to Lead Battle Against Alcohol Abuse 2Health News:Cancer-killing cells are caught on film in more 3-D detail than ever before 2Health News:Cancer-killing cells are caught on film in more 3-D detail than ever before 3Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 2Health News:Cleveland Clinic researchers awarded NIH grant to study concussion-identifying blood test 3Health News:Moffitt researchers find possible key to preventing chemotherapy resistance in ovarian cancer 2Health News:Not Enough Kids Drink Low-Fat Milk, U.S. Study Finds 2
(Date:9/2/2014)... Sept. 2, 2014 Reportlinker.com announces that ... its catalogue: BRIC Bariatric Surgery ... http://www.reportlinker.com/p02343483/BRIC-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html BRIC Bariatric Surgery ... Summary GlobalData,s new report, "BRIC Bariatric ... market data on the BRIC Bariatric Surgery Devices ...
(Date:9/2/2014)... 2, 2014 Perrigo Company plc, a public limited ... (the " Company "), today announced that it is ... its new 1.30% Senior Notes due 2016 (the " 2016 ... due 2018 (the " 2018 Exchange Notes "), $800,000,000 of ... Exchange Notes ") and $400,00,000 of its new 5.30% Senior ...
(Date:9/2/2014)... , Spanien und CALGARY, Alberta ... Vorgestellt in der "State of the Art ... 2014    Resverlogix Corp. (TSX: RVX) gab ... Medical Affairs bei Resverlogix, beim Kongress des europäischen Kardiologenverbandes ... einen Vortrag gehalten hat. In seinem Vortrag mit dem ...
Breaking Medicine Technology:BRIC Bariatric Surgery Devices Market Outlook to 2020 2BRIC Bariatric Surgery Devices Market Outlook to 2020 3BRIC Bariatric Surgery Devices Market Outlook to 2020 4BRIC Bariatric Surgery Devices Market Outlook to 2020 5BRIC Bariatric Surgery Devices Market Outlook to 2020 6BRIC Bariatric Surgery Devices Market Outlook to 2020 7BRIC Bariatric Surgery Devices Market Outlook to 2020 8BRIC Bariatric Surgery Devices Market Outlook to 2020 9BRIC Bariatric Surgery Devices Market Outlook to 2020 10Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 2RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 3RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 4RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 5RVX-208 führt bei Patienten mit Diabetes mellitus zu einer Verringerung des relativen Risikos von gravierenden unerwünschten Herzkreislaufereignissen um 77 % 6
... BEIJING , July 12 /PRNewswire-Asia-FirstCall/ -- Concord Medical ... CCM ), the,operator of the largest network of radiotherapy and ... as of July 1, 2010 it has entered,into ... Chang,An,Hospital,s cancer treatment facilities by acquiring a 52% equity interest ...
... , MOUNTAIN VIEW, Calif. , July 12 ... that it has selected AZ-007 ( Staccato zaleplon) for ... move forward into active development.  This decision follows an Alexza ...  In addition, Alexza has created Addicere Therapeutics, Inc., a wholly-owned ...
Cached Medicine Technology:Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 2Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 3Concord Medical Enters into Joint Venture Agreement with Chang'An Hospital 4Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 2Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 3Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 4Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 5Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 6Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 7Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy 8
... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
... Indirect Fluorescence Assay (IFA) for Anti-native ... for the qualitative and semi-quantitative detection ... nDNA in human serum. Detection of ... be used as an aid in ...
Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
... The Company's first commercial product is the ... single-use, disposable assay devices . The advantages ... are direct use of a vacuum-type blood ... result in minutes. VerifyNow IIb/IIIa, the first ...
Medicine Products: